Ocular Drug Delivery Technology Market to attain value of US$18.12 bn by 2025

1
Technology - Topical, Ocular Inserts
(Non-Erodible and Erodible), Iontophoresis,
Intraocular Implants (Biodegradable and
Non-Biodegradable), and In Situ Gel Punctal
Plugs Formulation Type - Suspension, Solution,
Emulsion, Liposomes Nanoparticles, and
Ointments Disease Type - Glaucoma, Diabetic
Retinopathy, Macular Degeneration, Diabetic
Macular Edema, and Cataract End User -
Hospitals, Ambulatory Surgical Centers,
Ophthalmic Clinics, and Homecare
SettingsForecast From 2017 - 2025
Ocular Drug Delivery Technology Market
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Ocular Drug Delivery Disease Type Market
Chapter 4 Market Overview
Chapter 5 Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
Chapter 6 Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 
Chapter 7 Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
Chapter 8 Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User
Chapter 9 Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
Chapter 10 North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
Chapter 11 Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
Chapter 12 Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
Chapter 13  Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
Chapter 14 Middle East Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
Chapter 15 Competition Landscape
3
Ocular Drug Delivery Technology Market Snapshot

• Ocular drug delivery is related to the ophthalmic
  diseases which affect the eye or parts of eyes.
• Growing aging population globally are more
  susceptible to suffer from vision impairment is
  creating the need for effective treatments and
  drugs are boosting adoption of ocular drug
  delivery and likely to bolster growth of the
  global ocular drug delivery market.
• Global ocular drug delivery technology market is
  segmented into topical, ocular inserts,
  intraocular implants, iontophoresis, and in situ
  gel punctal plugs. The ocular inserts segment
  is further classified in to non-erodible and
  erodible.

4
(No Transcript)
5
Reports Highlights

• Global ocular drug delivery technology market is
  expected to expand with a CAGR of 6.8 over the
  forecast period from 2017 to 2025 to attain value
  of US18.12 bn by the end of forecast period from
  US10.2 bn in 2016.
• Key Players OCULAR THERAPEUTIX, INC.,
  Allergan, Plc., Alimera Sciences, EyeGate Pharma,
  and Valeant Pharmaceuticals International, Inc.

Request Sample
6
(No Transcript)